Literature DB >> 17568020

Decreased effective blood volume in edematous disorders: what does this mean?

Robert W Schrier1.   

Abstract

Edematous patients with renal sodium and water retention, particularly cardiac failure and cirrhosis, have been suggested to have a decreased "effective blood volume." This enigmatic and undefined term was coined because edematous patients were found to have increased, rather than the earlier proposed decreased, blood volumes. This article discusses the advances that have occurred in understanding the pathophysiology of edema as occurs in conditions such as cardiac failure, cirrhosis, and pregnancy. The regulatory mechanisms that lead to increased sodium and water retention by the normal kidney are related to arterial underfilling, as a result of a decrease in cardiac output, arterial vasodilation, or both.

Entities:  

Mesh:

Year:  2007        PMID: 17568020     DOI: 10.1681/ASN.2006111302

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  41 in total

1.  A scaling law of vascular volume.

Authors:  Yunlong Huo; Ghassan S Kassab
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

Review 2.  Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?

Authors:  Gregory Valania; Manmeet Singh; Mara T Slawsky
Journal:  Curr Heart Fail Rep       Date:  2011-09

Review 3.  Diagnostic value of urinary sodium, chloride, urea, and flow.

Authors:  Robert W Schrier
Journal:  J Am Soc Nephrol       Date:  2011-08-18       Impact factor: 10.121

4.  Increased Spironolactone in Advanced Heart Failure: Effect of Doses Greater than 25 mg/Day on Plasma Potassium Concentration.

Authors:  Dmitry Shchekochikhin; JoAnn Lindenfeld; Robert Schrier
Journal:  Cardiorenal Med       Date:  2013-01-30       Impact factor: 2.041

Review 5.  Effects of limiting fluid intake on clinical and laboratory outcomes in patients with heart failure. Results of a meta-analysis of randomized controlled trials.

Authors:  R De Vecchis; C Baldi; C Cioppa; A Giasi; A Fusco
Journal:  Herz       Date:  2015-08-21       Impact factor: 1.443

6.  Volume depletion versus dehydration: how understanding the difference can guide therapy.

Authors:  Gautam Bhave; Eric G Neilson
Journal:  Am J Kidney Dis       Date:  2011-06-25       Impact factor: 8.860

7.  Differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction-results of a meta-analysis of randomized controlled trials.

Authors:  Renato De Vecchis; Carmelina Ariano
Journal:  Cardiovasc Diagn Ther       Date:  2017-06

Review 8.  Vasopressin receptor antagonists in patients with chronic heart failure.

Authors:  R De Vecchis; C Cantatrione; D Mazzei
Journal:  Herz       Date:  2016-09-15       Impact factor: 1.443

9.  Body fluids and salt metabolism - Part I.

Authors:  Mario G Bianchetti; Giacomo D Simonetti; Alberto Bettinelli
Journal:  Ital J Pediatr       Date:  2009-11-19       Impact factor: 2.638

Review 10.  Acid-Base Homeostasis.

Authors:  L Lee Hamm; Nazih Nakhoul; Kathleen S Hering-Smith
Journal:  Clin J Am Soc Nephrol       Date:  2015-11-23       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.